Federal Register / Vol. 72, No.
232 / Tuesday, December 4, 2007 / Notices 68167
5100 Paint Branch Pkwy., College Park,
MD 20740–3835, 301–436–1264.
SUPPLEMENTARY INFORMATION: Under the
Federal Food, Drug, and Cosmetic Act
(section 721e(d)(1) (21 U.S.C.
379e(d)(1))), notice is given that a color
additive petition (CAP 7C0284) has been
filed by DSM Nutritional Products, Inc.,
45 Waterview Blvd., Parsippany, NJ
07054. The petition proposes to amend
the color additive regulations in 21 CFR
part 73 to provide for the safe use of
astaxanthin dimethyldisuccinate as a
color additive in the feed of salmonid
fish to enhance the color of their flesh.
The agency has determined under 21
CFR 25.32(r) that this action is of a type
that does not individually or
cumulatively have a significant effect on
the human environment. Therefore,
neither an environmental assessment
nor an environmental impact statement
is required.
Dated: November 27, 2007.
Laura M. Tarantino,
Director, Office of Food Additive Safety,
Center for Food Safety and Applied Nutrition.
[FR Doc. E7–23473 Filed 12–3–07; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, Organ Specific Innate
Immunity.
Date: December 17, 2007.
mstockstill on PROD1PC66 with NOTICES
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge 6700, 6700B Rockledge Drive,
Room 3146, Bethesda, MD 20817 (Telephone
Conference Call).
VerDate Aug<31>2005 17:38 Dec 03, 2007 Jkt 214001
Contact Person: Kenneth E. Santora, PhD.,
Scientific Review Officer, Scientific Review
Program, NIH/NIAID/DHHS, Room 3146,
6700B Rockledge Drive, MSC 7616, Bethesda,
MD 20892, 301–451–2605, ks216i@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitation imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: November 26, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–5909 Filed 12–3–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel, MBRS—RISE and SCORE.
Date: December 11, 2007.
Time: 3 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892, (Telephone Conference Call).
Contact Person: Lisa Dunbar, PhD., Office
of Scientific Review, National Institute of
General Medical Sciences, National Institutes
of Health, 45 Center Drive, Room 3AN12,
Bethesda, MD 20892, 301–594–2849,
dunbarl@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 E:\FR\FM\04DEN1.SGM
Physiology, and Biological Chemistry
Research; 93.862, Genetics and Development
Biology Research; 93.88, Minority Access to
Research Careers; 93.96, Special Minority
Initiatives, National Institutes of Health,
HHS)
Dated: November 26, 2007.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–5910 Filed 12–3–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Advisory Mental Health
Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Mental Health Council.
Date: January 10–11, 2008.
Closed: January 10, 2008, 10 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications and review the activities of the
NIMH; Intramural Research Programs.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Conference Room C/D/E,
Rockville, MD 20852.
Open: January 11, 2008, 8:30 a.m. to 12:30
p.m.
Agenda: Presentation of NIMH Director’s
report and discussion on NIMH program and
policy issues.
Place: National Institutes of Health,
Building 31, 31 Center Drive, C Wing, 6th
Floor, Conference Room 6, Bethesda, MD
20892.
Contact Person: Jane A. Steinberg, PhD,
Director, Division of Extramural Activities,
04DEN1